Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Review uri icon

Overview

MeSH Major

  • Lung Neoplasms
  • Mass Screening

abstract

  • For high-risk populations, no screening modality has been shown to alter mortality outcomes. We recommend that individuals undergo screening only when it is administered as a component of a well-designed clinical trial with appropriate human subjects' protections.

publication date

  • September 2007

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1378/chest.07-1349

PubMed ID

  • 17873161

Additional Document Info

start page

  • 69S

end page

  • 77S

volume

  • 132

number

  • 3 SUPPL.